AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

25.11.2022 - AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on November 22, 2022 it received notification from the staff of the NYSE American (the ...

Related Keywords

United States ,American , ,Exchange Commission ,Youtube ,Linkedin ,Twitter ,Facebook ,Agex Therapeutics Inc ,About Agex ,Tissue Regeneration ,Private Securities Litigation Reform Act ,Agex Therapeutics ,Annual Report ,Quarterly Report ,Agex Therapeutics Stock ,